The technology is genuinely useful for scientific discovery, but its applications are less dramatic than you might think.

Under the partnership, Pharmaron will validate and promote the application of CN Bio’s PhysioMimix technology and will integrate OOC technologies into its R&D platform.

A new randomized study could cost Novavax tens of millions of dollars, vaccine experts say ...